Twisted DNA Increases CRISPR Off-target Effects
At the end of 2023, the FDA approved Casgevy for sickle cell disease, its first approval for a therapeutic that…
Bringing News as it Unfolds
At the end of 2023, the FDA approved Casgevy for sickle cell disease, its first approval for a therapeutic that…